1 Table of Contents
1.1 List of Tables
1.2 List of Tables

2 Introduction
2.1 Intraocular Lens (IOL) Overview

3 Products under Development
3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
3.2 Intraocular Lens (IOL) - Pipeline Products by Segment
3.3 Intraocular Lens (IOL) - Pipeline Products by Territory
3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials

4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies
4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development

5 Intraocular Lens (IOL) Companies and Product Overview

6 Intraocular Lens (IOL)- Recent Developments
6.1 Aug 10, 2022: STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
6.2 Jul 27, 2022: Bausch Health Companies will Release Second-Quarter 2022 Financial Results on Aug. 9
6.3 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
6.4 Jul 18, 2022: Carl Zeiss Meditec and Precise Bio announce partnership in the development and commercialization of tissue-based implants for ophthalmology
6.5 Jun 29, 2022: Visioneering Technologies welcomes Dr. Allan E. Rubenstein as Independent Director
6.6 Jun 23, 2022: Bausch + Lomb Announces Brett Icahn and Gary Hu Have Been Appointed to its Board of Directors
6.7 Jun 21, 2022: Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation
6.8 Jun 08, 2022: Bausch + Lomb Announces First-Quarter 2022 Results and Provides 2022 Guidance
6.9 May 30, 2022: Top Clean Injection invests in Teklyx software
6.10 May 25, 2022: Bausch + Lomb Will Release First-Quarter 2022 Financial Results on June 8
6.11 May 16, 2022: Bausch + Lomb Files Financial Statements for the First Quarter of 2022
6.12 Apr 29, 2022: Bausch Health Will Release First-Quarter 2022 Financial Results On May 10
6.13 Apr 28, 2022: Allergan, an AbbVie Company, to present new data from its leading portfolio of eye care treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
6.14 Apr 28, 2022: Bausch + Lomb will present new scientific data and analyses on products and pipeline programs during the association for research in vision and ophthalmology meeting
6.15 Apr 22, 2022: RxSight to Present at the Bank of America Healthcare Conference
6.16 Apr 18, 2022: Bausch + Lomb will present new scientific data during the American Society of Cataract and Refractive Surgery Annual Meeting
6.17 Mar 23, 2022: Santen Pharmaceutical Announces Change of Representative Director of the Board
6.18 Feb 03, 2022: Bausch Health Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23
6.19 Feb 03, 2022: Bausch Health Companies Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23
6.20 Jan 19, 2022: Rayner opens regional office in Australia as global commercial growth continues
6.21 Jan 11, 2022: Bausch Health Will Provide Business And Strategic Update At The 40th Annual JP Morgan Healthcare Conference
6.22 Jan 05, 2022: Bausch health to participate at the 40th annual J.P. Morgan healthcare conference
6.23 Jan 04, 2022: RxSight Appoints Dr. Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of Directors
6.24 Nov 10, 2021: RxSight Reports Third Quarter 2021 Financial Results
6.25 Nov 02, 2021: Bausch Health Companies Announces Third-Quarter 2021 Results
6.26 Sep 29, 2021: Bausch Health Releases Annual Environmental, Social and Governance Report

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Intraocular Lens (IOL) - Pipeline Products by Segment
Intraocular Lens (IOL) - Pipeline Products by Territory
Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Intraocular Lens (IOL) - Ongoing Clinical Trials
Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Glossary

List of Figures
Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Intraocular Lens (IOL) - Pipeline Products by Segment
Intraocular Lens (IOL) - Pipeline Products by Territory
Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Intraocular Lens (IOL) - Ongoing Clinical Trials

Companies Mentioned
- AcuFocus Inc
- Adaptilens LLC
- Adoptics AG (Inactive)
- AkkoLens International BV
- Alcon Inc
- Anew Optics, Inc.
- Atia Vision Inc
- Bausch & Lomb Inc
- Care Group
- Clarvista Medical Inc
- ClearSight LLC
- Cord LLC
- Elenza, Inc.
- Emmetrope Incorporated
- EyeKon Medical Inc
- Hoya Surgical Optics Inc
- Innovia LLC
- Johnson & Johnson Surgical Vision Inc
- Johnson & Johnson Vision Care Inc
- LensGen Inc
- London Eye Hospital
- Medicontur Medical Engineering Ltd
- Meir Medical Center
- Morcher Gmbh
- Nayam Innovations Pvt Ltd
- Nidek Co Ltd
- Northwestern University
- NuLens Ltd. (Inactive)
- Ocumetics Technology Corp
- PhysIOL SA
- PowerVision Inc
- Presbeasy
- Rayner Intraocular Lenses Ltd
- Sav-Iol SA
- Shanghai Haohai Biological Technology Co Ltd
- STAAR Surgical Company
- Strathspey Crown LLC
- Tianjin Century Kangtai Biomedical Engineering Co Ltd
- Ulsan National Institute of Science and Technology
- University of East Anglia
- University of Rochester
- University of Tampere
- Visidome Ltd
- Visioneering Technologies Inc
- VisusNano Labs
- Voptica SL
- VSY Biotechnology BV
- Washington University in St Louis
- Xend
- Z Lens LLC